Skip to content

Antibacterial Effects of Intracanal Medicaments in Acute Apical Abscesses

Comparative Evaluation of the Antibacterial Efficacy of Calcium Hydroxide and a Calcium Silicate-Based Intracanal Medicament in Teeth With Acute Apical Abscesses Using Real-Time PCR: A Randomized Clinical Trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07819240
Acronym
CAM-AAA
Enrollment
56
Registered
2026-09-14
Start date
2025-09-15
Completion date
2027-01-01
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Apical Abscess

Keywords

Endodontic Infection, Root Canal Treatment, Intracanal Medicament, Calcium Hydroxide, Calcium Silicate, Real-Time PCR, Bacterial Load

Brief summary

This randomized clinical trial compares the antibacterial effects of calcium hydroxide and a calcium silicate-based intracanal medicament in teeth with acute apical abscesses. Microbiological samples are collected before root canal preparation, after chemomechanical preparation, and after intracanal medication. Bacterial levels are measured using Real-Time PCR. The main objective is to determine which intracanal medicament provides a greater reduction in the total bacterial load after a 7- to 10-day medication period.

Detailed description

Acute apical abscess is an endodontic infection characterized by localized inflammation, pain, swelling, and purulent exudate. Although chemomechanical root canal preparation substantially reduces the bacterial load, microorganisms may remain within the root canal system. Intracanal medicaments are therefore used between treatment sessions to improve microbial reduction. In this randomized, parallel-group clinical trial, teeth diagnosed with acute apical abscess are allocated to receive either a calcium hydroxide intracanal medicament or a calcium silicate-based intracanal medicament. All teeth undergo standardized root canal treatment and irrigation procedures. Microbiological samples are collected at three main treatment stages: before chemomechanical preparation, after chemomechanical preparation and irrigation, and after a 7- to 10-day intracanal medication period. Bacterial DNA is analyzed using SYBR Green Real-Time PCR. Universal 16S rRNA primers are used to quantify the total bacterial load. Selected bacterial species associated with endodontic infections are also evaluated. The primary outcome is the change in total bacterial load between the post-instrumentation sample and the sample collected after intracanal medication. Secondary outcomes include changes in selected bacterial species and bacterial levels across the different sampling stages. The study aims to determine and compare the microbial effectiveness of the two intracanal medicaments in acute apical abscess cases.

Interventions

OTHERCalcium Hydroxide Intracanal Medicament

Calcium hydroxide-based intracanal medicament placed into the prepared root canal to 1 mm short of the working length for 7 to 10 days.

OTHERCalcium Silicate-Based Intracanal Medicament

Calcium silicate-based intracanal medicament placed into the prepared root canal to 1 mm short of the working length for 7 to 10 days.

Sponsors

Ataturk University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Masking description

Participants are unaware of the assigned intracanal medicament. Microbiological samples are coded, and the outcome assessor performing the Real-Time PCR measurements is unaware of group allocation.

Intervention model description

Participants are randomly assigned in parallel to receive either a calcium hydroxide or a calcium silicate-based intracanal medicament.

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Diagnosis of acute apical abscess * A single-rooted permanent tooth requiring primary endodontic treatment * Age between 18 and 65 years * No history of systemic disease * American Society of Anesthesiologists physical status classification I (ASA I) * Provision of written informed consent

Exclusion criteria

* Previous endodontic treatment of the affected tooth * Periodontal probing depth greater than 4 mm * History of trauma involving the affected tooth * Pregnancy or breastfeeding * Immunodeficiency

Design outcomes

Primary

MeasureTime frameDescription
Change in Total Bacterial Load After Intracanal MedicationFrom immediately after chemomechanical preparation to 7 to 10 days after intracanal medicament placementTotal bacterial load will be quantified using universal 16S rRNA gene-based Real-Time PCR in samples collected after chemomechanical root canal preparation (S2) and after the 7- to 10-day intracanal medication period (S3). The antibacterial effect will be evaluated as the change in log10 bacterial load from S2 to S3 and compared between the two intervention groups.

Secondary

MeasureTime frameDescription
Changes in the Levels of Selected Endodontic Bacterial SpeciesFrom before chemomechanical preparation to 7 to 10 days after intracanal medicament placementThe levels of Fusobacterium nucleatum, Prevotella intermedia, Porphyromonas endodontalis, Parvimonas micra, Treponema denticola, Streptococcus anginosus, Dialister pneumosintes, Campylobacter rectus, Filifactor alocis, and Olsenella uli will be evaluated using species-specific Real-Time PCR. Changes between the samples collected before chemomechanical preparation (S1), after chemomechanical preparation (S2), and after intracanal medication (S3) will be assessed and compared between the intervention groups.
Change in Total Bacterial Load After Chemomechanical PreparationFrom before to immediately after chemomechanical root canal preparation during the first treatment visitTotal bacterial load will be quantified using universal 16S rRNA gene-based Real-Time PCR in samples collected before chemomechanical root canal preparation (S1) and immediately after chemomechanical preparation (S2). The change in log10 bacterial load from S1 to S2 will be evaluated to determine the bacterial reduction achieved by the standardized chemomechanical preparation protocol.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 15, 2026